Mineralys director Brian Taylor Slingsby disposes of 104,320 common shares for $3 million
Bitget2026/09/25 01:50- Mineralys Therapeutics director Brian Taylor Slingsby disclosed a sale of 104,320 common shares on Sep. 22, 2026.
- Transaction price was USD 28.8085 per share.
- Indirect holdings stood at 7,805,718 shares following the sale.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Raphael Zagury: Bitcoin will eventually surpass gold
Federal Reserve Bowman: AI Brings Both Opportunities and Risks to the Banking Industry, Fed Urges Strengthening of System Security Protections
Federal Reserve Vice Chair for Supervision, Bowman, warned that AI has a dual impact on the banking industry, serving both as a defensive tool and introducing new emerging risks. She urged banks to strengthen basic cybersecurity measures, including updating asset inventories, deploying multi-factor authentication, and improving vulnerability management. Bowman also stated that regulators will continue to adjust their examination approaches, implementing differentiated supervision for community banks instead of imposing blanket mandatory requirements.
FingerMotion to Buy Newbit Technology for $2.3 Million
BUZZ - Pyxis Oncology shares decline after launching equity financing
Crypto prices
More
